The increased risk for a rare optic nerve disorder may not tarnish the game-changer reputation of the GLP-1 drugs. Medscape
Author: Medscape
Does This Side Effect Spell Doom for the GLP-1s?
The increased risk for a rare optic nerve disorder may not tarnish the game-changer reputation of the GLP-1 drugs. Medscape
New Anti-VEGF Agents Extend Dosing Intervals in Wet AMD
New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans. Medscape Medical News
Rare Eye Disease Gets First NHS Drug Recommendation
NICE’s recommendation of idebenone (Raxone) for Leber hereditary optic neuropathy offers hope for patients against visual impairment. Medscape News UK
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
As Copay Aid Recedes, Retina Treatment ‘Unsustainable’
A new study finds cuts in copay assistance for retina injections are harming lower-income communities and leading to poorer vision outcomes. Medscape Medical News
Port Delivery System Outperforms Injections for DME
In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical response than intravitreal injection the other, a new study shows. Medscape Medical News
Retina Tear Raises Detachment Risk After Cataract Surgery
Delaying cataract surgery 6 months or more after laser for retina tears reduces the risk for retinal detachment by half, a new study shows. Medscape Medical News
FDA Approves VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
FDA Approves of VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
GLP-1 RAs May Up Optic Neuropathy Risk in Seniors With Diabetes
Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes, a study of Medicare enrollees shows. Medscape Medical News
GLP-1 Users May Face Optic Nerve Damage Risk in First Year
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity. Medscape Medical News
Veligrotug Shows Promise for Treating Thyroid Eye Disease
The THRIVE and THRIVE-2 clinical trials showed significant improvements in proptosis and diplopia in active as well as chronic thyroid eye disease, earning FDA Breakthrough Therapy designation. Medscape Medical News
Can Medicare Afford the Perpetual Human?
As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer and healthier life. Medscape Medical News
Continuous Use of Tear Drops Eases Dry Eye Symptoms in AMD
Continuous use of eye drops in patients with neovascular AMD who receive frequent eye injections soothes dry eye more effectively than intermittent use, a new study shows. Medscape Medical News
NIH Launches Agency-Wide Plan for Autoimmune Research
The 5-year strategy aims to accelerate diagnosis, prevention, and treatment for the millions living with autoimmune diseases in the US. Medscape Medical News
Experts Warn of Hidden Psychological Burden in Glaucoma
Anxiety and depression are more common among people with glaucoma than in the general population but often go unrecognized, highlighting the need for routine psychometric screening in this population, a new study finds. Medscape Medical News
Identifying, Referring Cataracts in Primary Care
Cataracts can happen at any age, but risk is heightened in older adults and people with diabetes. Medscape Medical News
Sleep Apnea Can Raise Risk for Retinal Vein Disease
A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is associated with worse outcomes in patients who already have the condition. Medscape Medical News